Income Statement (TTM)
bioXXmed AG Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | -0.25 | -19.06 | -23.55 | 50.16 | 33.41 | -0.17 | -0.16 | -36.25 | -56.86 | 33.85 | 25.28 | -7.59 | -8.20 | -35.66 | -55.41 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | ||||||||||||||||
| Change (%) | ||||||||||||||||
| % of Revenue | ||||||||||||||||
| Gross Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | -0.25 | -19.06 | -23.55 | 50.16 | 33.41 | -0.17 | -0.16 | -36.25 | -56.86 | 33.85 | 25.28 | -7.59 | -8.20 | -35.66 | -55.41 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | 14.15 | -15.10 | -17.78 | 0.55 | 0.55 | -17.55 | -21.28 | -49.50 | -98.03 | 50.06 | 33.34 | 4.39 | 4.22 | 3.58 | 3.45 | |
| % of Revenue | 1,889.44 | 2,162.18 | 2,267.95 | 2,438.97 | 1,633.20 | 1,230.93 | 1,016.61 | 801.56 | 634.89 | 28.97 | 32.48 | 34.57 | 39.04 | 44.32 | 71.35 | 165.55 |
| R&D | ||||||||||||||||
| Change (%) | ||||||||||||||||
| % of Revenue | ||||||||||||||||
| OpEx | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | 16.21 | -2.83 | -2.92 | -4.37 | -4.57 | -4.66 | -4.89 | -21.46 | -27.33 | -7.74 | -8.39 | 8.34 | 7.70 | 2.15 | 2.10 | |
| % of Revenue | 4,469.58 | 5,207.18 | 6,251.02 | 7,938.17 | 5,055.58 | 3,616.49 | 3,453.71 | 3,290.32 | 4,053.20 | 6,827.67 | 4,706.26 | 3,441.44 | 4,034.51 | 4,733.08 | 7,514.25 | 17,207.03 |
| Operating Income | -2 | -2 | -2 | -2 | -2 | -2 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| Change (%) | 16.59 | -2.51 | -2.58 | -5.06 | -5.33 | -4.79 | -5.03 | -21.00 | -26.58 | -8.36 | -9.12 | 8.82 | 8.10 | 2.96 | 2.88 | |
| % of Revenue | -4,369.57 | -5,107.18 | -6,151.02 | -7,838.17 | -4,955.57 | -3,516.49 | -3,353.71 | -3,190.32 | -3,953.20 | -6,727.67 | -4,606.26 | -3,341.44 | -3,934.51 | -4,633.08 | -7,414.25 | -17,107.03 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||
| Change (%) | -97.74 | 3.48 | 3.24 | 77.56 | 43.68 | 666.62 | 86.96 | 18.70 | 15.75 | -33.91 | -51.32 | -50.00 | ||||
| % of Revenue | -95.17 | -2.16 | -2.76 | -3.72 | -4.40 | -4.74 | -36.39 | -68.15 | -126.89 | -340.49 | -168.11 | -65.32 | -35.34 | |||
| Net Income | -2 | -2 | -2 | -2 | -3 | -4 | -4 | -4 | -2 | -1 | -1 | -1 | -11 | -21 | -21 | -21 |
| Change (%) | 13.47 | -2.54 | -2.61 | 66.25 | 39.85 | -1.49 | -1.51 | -39.46 | -65.19 | -10.19 | -11.35 | 1,535.35 | 93.89 | 0.12 | 0.12 | |
| % of Revenue | -4,491.36 | -5,108.88 | -6,151.55 | -7,836.80 | -8,676.47 | -9,095.43 | -8,974.65 | -8,853.27 | -8,406.53 | -6,783.59 | -4,551.57 | -3,220.78 | -56,993.99 | -120,369.63 | -187,307.55 | -420,594.43 |
Source: Capital IQ
